Hereditary Cancer
While cancer itself is not hereditary, a person can inherit certain mutations and genes that may cause a higher than normal chance of cancer manifesting. This can be seen when several family members manifest the same type of cancer. Common cancers that are considered hereditary are breast, and ovarian cancer, among others.
What's Popular in Hereditary Cancer
NOV 12, 2020
3:00 PM PST
C.E. CREDITS
NOV 12, 2020
3:00 PM PST
What if your lab could perform exome sequencing with the same sensitivity and efficiency of targeted sequencing? The new integrated QIAseq Human Exome TR Insights solution from QIAGEN delive...
OCT 22, 2020
1:15 PM PDT
OCT 22, 2020
1:15 PM PDT
To identify genetic variants in archival human samples, researchers need a powerful NGS platform that can accommodate input DNA and RNA that is often low quality and/or low quantity. This ch...
OCT 08, 2020
10:00 AM PDT
C.E. CREDITS
OCT 08, 2020
10:00 AM PDT
DATE: October 8, 2020 TIME: 1:00pm PDT Microsatellite instability (MSI) has evolved as a marker of potential hereditary cancer risk and is now a tissue agnostic immune biomarker with a broad...
OCT 08, 2020
10:00 AM PDT
C.E. CREDITS
OCT 08, 2020
10:00 AM PDT
DATE: October 8, 2020 TIME: 1:00pm PDT Microsatellite instability (MSI) has evolved as a marker of potential hereditary cancer risk and is now a tissue agnostic immune biomarker with a broad...
C.E. CREDITS
Learning Objectives: 1. To provide an overview of relevant hereditary cancer syndromes 2. To encourage providers to obtain a thorough family history 3. To educate providers about available r...
JUL 02, 2020
2:00 PM SGT
JUL 02, 2020
2:00 PM SGT
Theragen Bio. (TheragenEtex Subsidiary company) has been conducted the genome-wide research and the genome-based genetic testing services. From 2007, researchers of Theragen Bio. are collabo...
MAY 08, 2020
8:00 AM PDT
MAY 08, 2020
8:00 AM PDT
DATE: May 8, 2020 TIME: 8:00am PT, 11:00am ET Microsatellite instability (MSI) is the condition of genetic hypermutability that results from impaired DNA mismatch repair (MMR). Studies indic...
In this presentation Dr. Kevin Halling describes the use of RNA-seq testing for identifying clinically significant gene fusions in tumors that can be used to help establish diagnosis and gui...
